drugset / Trial / NCT03065868

Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp

NCT03065868

Phase 4 Completed 32 enrolled Kyungpook National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the effect of H. pylori eradication on regression of H. pylori-related gastric polyp (Ranomized controlled trial) 1. Study design: open labeled RCT 2. Study group H. pylori eradication group (N=17), non-eradication group (N=15) 3. Treatment plan 1. Baseline EGD : 0.3-1cm sized polyp - bx \& CLO test (antrum \& body) ==\> if H. pylori positive and eligible patients, randomization 2. Triple therapy 3. UBT (4week after eradication) 4. Follow-up EGD: gross finding, CLO test 4. Evaluation of polyp regression 1. disappear 2. regression over 50% (size, number) 3. no change or increase (size, number)

Timeline

Start
2015-12-09
Primary completion
2019-04-30
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxaxillin Unknown
Subject Clarithromycin Small molecule
Subject Lanston Unknown